Sponsor:
Fate Therapeutics
Code:
NCT07216105
Conditions
Non-Small Cell Lung Cancer
Colorectal Cancer
Breast Cancer
Ovarian Cancer
Endometrial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT836
Paclitaxel
Cetuximab
Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-19. This information was provided to ClinicalTrials.gov by Fate Therapeutics on 2025-10-14.